← Back to headlines
Roche Lymphoma Therapy Undergoes FDA Review for Label Expansion
Roche's lymphoma therapy is currently undergoing review by the FDA for a potential expansion of its approved label.
18 Jun, 10:53 — 18 Jun, 10:53
Sources
Showing 1 of 1 sources
